Put Options

29 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$194.69 - $268.46 $5.78 Million - $7.97 Million
-29,700 Reduced 14.72%
172,100 $46 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $5.78 Million - $7.97 Million
-29,700 Reduced 14.72%
172,100 $46 Million
Q2 2022

Sep 21, 2023

BUY
$187.54 - $223.02 $20.8 Million - $24.7 Million
110,700 Added 121.51%
201,800 $41.2 Million
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $20.8 Million - $24.7 Million
110,700 Added 121.51%
201,800 $41.2 Million
Q1 2022

Sep 21, 2023

SELL
$193.77 - $244.14 $12.1 Million - $15.3 Million
-62,700 Reduced 40.77%
91,100 $19.2 Million
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $12.1 Million - $15.3 Million
-62,700 Reduced 40.77%
91,100 $19.2 Million
Q4 2021

Sep 21, 2023

BUY
$223.92 - $287.77 $9.2 Million - $11.8 Million
41,100 Added 36.47%
153,800 $36.9 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $9.2 Million - $11.8 Million
41,100 Added 36.47%
153,800 $36.9 Million
Q3 2021

Sep 21, 2023

BUY
$282.99 - $369.05 $17 Million - $22.1 Million
60,000 Added 113.85%
112,700 $31.9 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $17 Million - $22.1 Million
60,000 Added 113.85%
112,700 $31.9 Million
Q2 2021

Sep 21, 2023

SELL
$259.0 - $414.71 $41.9 Million - $67.1 Million
-161,900 Reduced 75.44%
52,700 $18.2 Million
Q2 2021

Aug 20, 2021

SELL
$259.0 - $414.71 $1.35 Billion - $2.16 Billion
-5,217,300 Reduced 99.0%
52,700 $18.2 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $1.31 Billion - $2.1 Billion
5,055,400 Added 2355.73%
5,270,000 $18.2 Million
Q1 2021

Sep 21, 2023

BUY
$242.95 - $284.63 $48 Million - $56.2 Million
197,600 Added 1162.35%
214,600 $60 Million
Q1 2021

May 14, 2021

BUY
$242.95 - $284.63 $48 Million - $56.2 Million
197,600 Added 1162.35%
214,600 $60 Million
Q4 2020

Sep 21, 2023

SELL
$236.26 - $355.63 $36.6 Million - $55.2 Million
-155,100 Reduced 90.12%
17,000 $4.16 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $3.12 Million - $4.69 Million
13,200 Added 347.37%
17,000 $4.16 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $17.1 Million - $22.7 Million
-66,200 Reduced 94.57%
3,800 $1.02 Million
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $2.53 Million - $3.21 Million
-9,400 Reduced 11.84%
70,000 $22.1 Million
Q4 2019

Feb 13, 2020

BUY
$220.06 - $304.07 $3.32 Million - $4.59 Million
15,100 Added 23.48%
79,400 $23.6 Million
Q3 2019

Nov 13, 2019

BUY
$217.44 - $243.88 $1.96 Million - $2.19 Million
9,000 Added 16.27%
64,300 $15 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $12 Million - $13.2 Million
54,700 Added 9116.67%
55,300 $12.9 Million
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $238,381 - $372,856
-1,100 Reduced 64.71%
600 $142,000
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $20 Million - $25.4 Million
-71,900 Reduced 97.69%
1,700 $512,000
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $20.6 Million - $26.9 Million
70,100 Added 2002.86%
73,600 $26 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $7.34 Million - $8.75 Million
-28,500 Reduced 89.06%
3,500 $1.02 Million
Q1 2018

May 15, 2018

BUY
$260.13 - $367.91 $6.56 Million - $9.27 Million
25,200 Added 370.59%
32,000 $8.76 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $1.94 Million - $2.17 Million
-6,300 Reduced 48.09%
6,800 $2.17 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $3.68 Million - $4.32 Million
13,100
13,100 $4.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $33.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.